cetylpyridinium has been researched along with Grippe in 4 studies
Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prior influenza vaccination had no effect on study outcome." | 2.84 | Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. ( Adkins, I; Arters, K; Buchheit, K; Esper, F; Ghannoum, MA; Mukherjee, PK; Salata, RA, 2017) |
| "Reduction in density of influenza viral protein hemagglutinin (HA) clusters is known to reduce influenza infectivity: here, we show that CPC (at non-cytotoxic doses, 5-10 μM) reduces HA density and number of HA molecules per cluster within the plasma membrane of NIH-3T3 mouse fibroblasts." | 1.72 | Cetylpyridinium chloride (CPC) reduces zebrafish mortality from influenza infection: Super-resolution microscopy reveals CPC interference with multiple protein interactions with phosphatidylinositol 4,5-bisphosphate in immune function. ( Burnell, JE; Gosse, JA; Hess, ST; King, BL; Kinney, MS; Obeng, B; Potts, CM; Raut, P; Sangroula, S; Soos, BL; Weller, SR; West, BE, 2022) |
| "Whether the absence rate due to common cold and influenza changed by encouraging the use of the PVP-I gargle was determined by comparing a middle school where the PVP-I gargle was used and other middle schools where it was not." | 1.31 | Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations. ( Nakagawa, Y; Shiraishi, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raut, P | 1 |
| Weller, SR | 1 |
| Obeng, B | 1 |
| Soos, BL | 1 |
| West, BE | 1 |
| Potts, CM | 1 |
| Sangroula, S | 1 |
| Kinney, MS | 1 |
| Burnell, JE | 1 |
| King, BL | 1 |
| Gosse, JA | 1 |
| Hess, ST | 1 |
| Mukherjee, PK | 1 |
| Esper, F | 1 |
| Buchheit, K | 1 |
| Arters, K | 1 |
| Adkins, I | 1 |
| Ghannoum, MA | 1 |
| Salata, RA | 1 |
| Shiraishi, T | 1 |
| Nakagawa, Y | 1 |
| Mahlberg, FA | 1 |
| Rodermund, OE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo to Prevent Acute Upper Respiratory Disease and Respiratory Virus Infections[NCT02644135] | 100 participants (Actual) | Interventional | 2013-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Measured by medical record review. (NCT02644135)
Timeframe: Through study duration, an average of 3 months
| Intervention | Number of acute respiratory illnesses (Number) |
|---|---|
| Halo Oral Spray | 4 |
| Halo Placebo | 2 |
(NCT02644135)
Timeframe: Through study duration, an average of 3 months
| Intervention | participants (Number) |
|---|---|
| Halo Oral Spray | 2 |
| Halo Placebo | 4 |
1 trial available for cetylpyridinium and Grippe
| Article | Year |
|---|---|
Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Infective Agents, Local; Cety | 2017 |
3 other studies available for cetylpyridinium and Grippe
| Article | Year |
|---|---|
Cetylpyridinium chloride (CPC) reduces zebrafish mortality from influenza infection: Super-resolution microscopy reveals CPC interference with multiple protein interactions with phosphatidylinositol 4,5-bisphosphate in immune function.
Topics: Animals; Cell Communication; Cetylpyridinium; COVID-19; Humans; Immunity; Influenza, Human; Mammals; | 2022 |
Evaluation of the bactericidal activity of povidone-iodine and commercially available gargle preparations.
Topics: Adolescent; Adult; Anti-Infective Agents, Local; Cetylpyridinium; Common Cold; Humans; Influenza, Hu | 2002 |
[Periorbital purpura in influenza infection after cetylpyridium chloride?].
Topics: Adolescent; Cetylpyridinium; Drug Eruptions; Drug Hypersensitivity; Humans; Influenza, Human; Male; | 1976 |